Diabetes & Obesity (posters)

LBSU-1078

Association of Glycemic Control, Inflammatory Markers and Peri-Operative Complications in Patients Undergoing CABG
Francisco J Pasquel, Priyathama Vellanki, Saumeth Cardona, Isabel Anzola, Maya Fayfman, Limin Peng, Dawn Smiley and Guillermo E Umpierrez

LBSU-1080

Empagliflozin (EMPA) for ≥76 Weeks As Add-on to Pioglitazone with or without Metformin in Patients with Type 2 Diabetes (T2DM)
Christopher Simon Kovacs, Veeraswamy Seshiah, Ludwig Merker, Anita Vedel Christiansen, Flavien Roux, Afshin Salsali, Gabriel Kim, Peter Stella, Hans-Juergen Woerle and Uli C Broedl

LBSU-1081

Empagliflozin (EMPA) Monotherapy for ≥76 Weeks in Drug-Naïve Patients with Type 2 Diabetes (T2DM)
Michael W. Roden, Jianping Weng, Ludwig Merker, Anita Vedel Christiansen, Flavien Roux, Afshin Salsali, Gabriel Kim, Peter Stella, Hans-Juergen Woerle and Uli C Broedl

LBSU-1082

Empagliflozin (EMPA) for ≥76 Weeks As Add-on to Metformin in Patients with Type 2 Diabetes (T2DM)
Ludwig Merker, Hans-Ulrich Haering, Anita Vedel Christiansen, Flavien Roux, Afshin Salsali, Gabriel Kim, Thomas Meinicke, Hans-Juergen Woerle and Uli C Broedl

LBSU-1086

Loss of Sirtuin 4 Leads to Insulin Resistance in Mice
Frank K Huynh and Matthew D Hirschey

LBSU-1087

Generation and Characterization of Reporter Mice to Monitor Pdx1 and Mafa Promoter Activity
Wataru Nishimura, Nobuaki Funahashi, Haruhide Udagawa, Miho Kawaguchi, Takao Nammo, Hisashi Oishi, Satoru Takahashi and Kazuki Yasuda